Evidence that 5‐HT<sub>2A</sub> receptor signalling efficacy and not biased agonism differentiates serotonergic psychedelic from non‐psychedelic drugs

In summary, all psychedelic drugs tested were unbiased, partial 5-HT<sub>2A</sub> receptor agonists. Importantly, the non-psychedelic drugs lisuride, TBG and IHCH-7079 were discriminated from psychedelic drugs, not through ligand bias but rather by low efficacy. Therefore, low 5-HT<sub>2A</sub> receptor signalling efficacy may explain why some 5-HT<sub>2A</sub> receptor agonists are not psychedelic, although a larger panel of drugs should be tested to confirm this idea.

Authors

Institutions

Publication Details

Journal
British Journal of Pharmacology
Published
2025-06-22
DOI
https://doi.org/10.1111/bph.70109
Citations
4
Primary Topic
Psychedelics and Drug Studies
Type
article
Field-Weighted Citation Impact
9.23

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Evidence that 5‐HT2A receptor signalling efficacy and not biased agonism differentiates serotonergic psychedelic from non‐psychedelic drugs

Sridhar R. Vasudevan, Shaun Hurley, Grant C. Churchill, Trevor Sharp et al.
4 citations
British Journal of Pharmacology
Psychedelics and Drug Studies
9.23
article

Evidence that 5‐HT2A receptor signalling efficacy and not biased agonism differentiates serotonergic psychedelic from non‐psychedelic drugs

Sridhar R. Vasudevan, Shaun Hurley, Grant C. Churchill, Trevor Sharp, Frederick G. Westhorpe, Gary Gilmour, Aurelija Ippolito
article en
4 citations

Abstract

In summary, all psychedelic drugs tested were unbiased, partial 5-HT<sub>2A</sub> receptor agonists. Importantly, the non-psychedelic drugs lisuride, TBG and IHCH-7079 were discriminated from psychedelic drugs, not through ligand bias but rather by low efficacy. Therefore, low 5-HT<sub>2A</sub> receptor signalling efficacy may explain why some 5-HT<sub>2A</sub> receptor agonists are not psychedelic, although a larger panel of drugs should be tested to confirm this idea.

British Journal of Pharmacology
University of Oxford (GB), Pathways Behavioral Services (US)
Medical Research Council
Reduced inequalities
Openalex Percentile: Top 2%
Psychedelics and Drug Studies
9.23
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Evidence that 5‐HT<sub>2A</sub> receptor signalling efficacy and not biased agonism differentiates serotonergic psychedelic from non‐psychedelic drugs — Sridhar R. Vasudevan, Shaun Hurley, et al. · British Journal of Pharmacology (2025) | TGRS Research Map | TGRS